Clinical trial
Safety and Efficacy of Dextromethorphan and Quinidine in the Treatment of the…
NCT00113620 · Avanir Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00113620 |
|---|---|
| Title | Safety and Efficacy of Dextromethorphan and Quinidine in the Treatment of the Pain of Diabetic Neuropathy |
| Official title | A Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of Dextromethorphan and Quinidine at Two Dose Levels in the Treatment of the Pain of Diabetic Neuropathy |
| Lead sponsor | Avanir Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pain, Diabetic Neuropathy |
| Intervention type | Drug |
| Interventions | Neurodex |
| Enrollment | 450 |
| Start date | Jul 1, 2005 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | Jun 10, 2005 |
| Last update posted | Jul 14, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: